medication dangers 101

What are Risperdal and Invega?

Risperdal (risperidone) and Invega (paliperidone) are powerful second-generation antipsychotics approved for the treatment of schizophrenia in adults and adolescents and are both manufactured by Johnson & Johnson's Janssen Pharmaceuticals unit. Risperdal is also approved to treat bipolar disorder in adults and adolescents, and autism spectrum disorders in children and adolescents. Invega is also approved to treat schizoaffective disorder.
Risperdal is also available in a long-acting injection called Risperdal Consta. J&J also released authorized generic risperidone though another of its subsidiaries, Patriot.
These drugs are also used “off label” for attention deficit hyperactivity disorder (ADHD), anxiety, sleep difficulties and depression.
Risperdal was first approved by the Food and Drug Administration (FDA) to treat schizophrenia in 1993, and Invega in 2006. The FDA later expanded their approved uses.